Gulf Inject, a unit of Julphar – a leading pharmaceutical manufacturer in the region, has signed a local distribution agreement with Zulekha Healthcare Group.
The event was held at the Gulf Inject manufacturing facility located in the Jebel Ali Free Zone, Dubai, in the presence of dignitaries and representatives from both companies, said a statement.
Launched in 1994, Gulf Inject produces world-class intravenous (IV) fluids and has established itself as a regional leader in fluid management.
The facility was upgraded in 2013 to comply with current GMP requirements and its local partnership agreement with Zulekha Healthcare Group is expected to positively impact current business in the UAE, it said.
Gulf Inject’s general manager Dr Ashraf Abu Arrah said: “Our vision is to be a leader in the formulation of sterile solutions in the region and I strongly believe that our newly-signed distribution agreement with the well-established healthcare service provider Zulekha will help us achieve our goal and better serve the local healthcare community.”
Anubhav Gautam, managing director at Royal Care Medical and Channel Partner Zulekha Store, said: “The agreement will tremendously change the existing business environment.”
“Gulf inject is a market leader in its product range and we are well-known in the GCC in the supply chain management field,” he said.
“This partnership can only benefit both parties by bringing in new synergy and stability in their respective business,” he concluded. – TradeArabia News Service